View Financial HealthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsNeurone Studio 배당 및 자사주 매입배당 기준 점검 0/6Neurone Studio 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률-21.9%자사주 매입 수익률총 주주 수익률-21.9%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updatesBuy Or Sell Opportunity • Mar 03Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 14% to €0.24. The fair value is estimated to be €0.31, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 26%.공시 • Feb 11Neurone Studio S.A. to Report Q4, 2025 Results on Feb 13, 2026Neurone Studio S.A. announced that they will report Q4, 2025 results on Feb 13, 2026Buy Or Sell Opportunity • Jan 16Now 21% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.25. The fair value is estimated to be €0.31, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 26%.Buy Or Sell Opportunity • Dec 31Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 12% to €0.23. The fair value is estimated to be €0.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 26%.New Risk • Dec 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 5.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m. Market cap is less than US$10m (€672.0k market cap, or US$781.2k). Minor Risks Share price has been volatile over the past 3 months (5.7% average weekly change). Shareholders have been diluted in the past year (26% increase in shares outstanding).Buy Or Sell Opportunity • Dec 08Now 25% undervalued after recent price dropOver the last 90 days, the stock has fallen 16% to €0.22. The fair value is estimated to be €0.29, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 26%.공시 • Nov 11Neurone Studio S.A. to Report Q3, 2025 Results on Nov 13, 2025Neurone Studio S.A. announced that they will report Q3, 2025 results on Nov 13, 2025New Risk • Sep 14New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 26% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł213k free cash flow). Revenue is less than US$1m. Market cap is less than US$10m (€909.9k market cap, or US$1.07m). Minor Risk Shareholders have been diluted in the past year (26% increase in shares outstanding).New Risk • Sep 05New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -zł213k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł213k free cash flow). Revenue is less than US$1m. Market cap is less than US$10m (€671.6k market cap, or US$789.4k).New Risk • Mar 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł324k free cash flow). Negative equity (-zł141k). Revenue is less than US$1m. Market cap is less than US$10m (€837.4k market cap, or US$868.5k). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Share price has been volatile over the past 3 months (11% average weekly change).New Risk • Nov 26New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł324k free cash flow). Negative equity (-zł141k). Revenue is less than US$1m. Market cap is less than US$10m (€484.6k market cap, or US$507.7k). Minor Risk Share price has been volatile over the past 3 months (7.1% average weekly change).공시 • Jun 18Neurone Studio S.A., Annual General Meeting, Jul 11, 2024Neurone Studio S.A., Annual General Meeting, Jul 11, 2024.공시 • Jan 31+ 3 more updatesNeurone Studio S.A. to Report Q3, 2024 Results on Nov 14, 2024Neurone Studio S.A. announced that they will report Q3, 2024 results on Nov 14, 2024New Risk • Aug 25New major risk - Negative shareholders equityThe company has negative equity. Total equity: -zł6.8k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł329k free cash flow). Negative equity (-zł6.8k). Revenue is less than US$1m (zł250 revenue, or US$60.0). Market cap is less than US$10m (€982.7k market cap, or US$1.06m). Minor Risk Shareholders have been diluted in the past year (3.4% increase in shares outstanding).공시 • Jun 04Neurone Studio S.A., Annual General Meeting, Jun 30, 2023Neurone Studio S.A., Annual General Meeting, Jun 30, 2023, at 11:00 Central European Standard Time.공시 • Jan 26+ 2 more updatesNeurone Studio S.A. to Report Q3, 2023 Results on Nov 13, 2023Neurone Studio S.A. announced that they will report Q3, 2023 results on Nov 13, 2023공시 • Jun 08Neurone Studio S.A., Annual General Meeting, Jun 30, 2022Neurone Studio S.A., Annual General Meeting, Jun 30, 2022, at 13:00 Central European Standard Time.공시 • Feb 02+ 4 more updatesNeurone Studio S.A. to Report Q3, 2022 Results on Nov 11, 2022Neurone Studio S.A. announced that they will report Q3, 2022 results on Nov 11, 2022Is New 90 Day High Low • Feb 13New 90-day low: €0.71The company is down 22% from its price of €0.92 on 13 November 2020. The German market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Entertainment industry, which is up 13% over the same period.공시 • Jan 29+ 3 more updatesNeurone Studio S.A. to Report Fiscal Year 2020 Results on May 27, 2021Neurone Studio S.A. announced that they will report fiscal year 2020 results on May 27, 2021Is New 90 Day High Low • Oct 26New 90-day low: €0.85The company is down 27% from its price of €1.17 on 28 July 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Entertainment industry, which is up 20% over the same period.Is New 90 Day High Low • Sep 29New 90-day low: €0.85The company is down 14% from its price of €1.00 on 01 July 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Entertainment industry, which is up 8.0% over the same period.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 6SH 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: 6SH 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Neurone Studio 배당 수익률 vs 시장6SH의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (6SH)n/a시장 하위 25% (DE)1.5%시장 상위 25% (DE)4.5%업계 평균 (Entertainment)2.6%분석가 예측 (6SH) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 6SH 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 6SH 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 6SH 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: 6SH 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YDE 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/01 10:01종가2026/04/29 00:00수익2025/09/30연간 수익2024/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Neurone Studio S.A.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Buy Or Sell Opportunity • Mar 03Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 14% to €0.24. The fair value is estimated to be €0.31, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 26%.
공시 • Feb 11Neurone Studio S.A. to Report Q4, 2025 Results on Feb 13, 2026Neurone Studio S.A. announced that they will report Q4, 2025 results on Feb 13, 2026
Buy Or Sell Opportunity • Jan 16Now 21% undervaluedThe stock has been flat over the last 90 days, currently trading at €0.25. The fair value is estimated to be €0.31, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 26%.
Buy Or Sell Opportunity • Dec 31Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 12% to €0.23. The fair value is estimated to be €0.28, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 26%.
New Risk • Dec 09New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 5.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m. Market cap is less than US$10m (€672.0k market cap, or US$781.2k). Minor Risks Share price has been volatile over the past 3 months (5.7% average weekly change). Shareholders have been diluted in the past year (26% increase in shares outstanding).
Buy Or Sell Opportunity • Dec 08Now 25% undervalued after recent price dropOver the last 90 days, the stock has fallen 16% to €0.22. The fair value is estimated to be €0.29, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 165% over the last 3 years. Earnings per share has grown by 26%.
공시 • Nov 11Neurone Studio S.A. to Report Q3, 2025 Results on Nov 13, 2025Neurone Studio S.A. announced that they will report Q3, 2025 results on Nov 13, 2025
New Risk • Sep 14New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 26% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł213k free cash flow). Revenue is less than US$1m. Market cap is less than US$10m (€909.9k market cap, or US$1.07m). Minor Risk Shareholders have been diluted in the past year (26% increase in shares outstanding).
New Risk • Sep 05New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -zł213k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł213k free cash flow). Revenue is less than US$1m. Market cap is less than US$10m (€671.6k market cap, or US$789.4k).
New Risk • Mar 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł324k free cash flow). Negative equity (-zł141k). Revenue is less than US$1m. Market cap is less than US$10m (€837.4k market cap, or US$868.5k). Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Share price has been volatile over the past 3 months (11% average weekly change).
New Risk • Nov 26New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł324k free cash flow). Negative equity (-zł141k). Revenue is less than US$1m. Market cap is less than US$10m (€484.6k market cap, or US$507.7k). Minor Risk Share price has been volatile over the past 3 months (7.1% average weekly change).
공시 • Jun 18Neurone Studio S.A., Annual General Meeting, Jul 11, 2024Neurone Studio S.A., Annual General Meeting, Jul 11, 2024.
공시 • Jan 31+ 3 more updatesNeurone Studio S.A. to Report Q3, 2024 Results on Nov 14, 2024Neurone Studio S.A. announced that they will report Q3, 2024 results on Nov 14, 2024
New Risk • Aug 25New major risk - Negative shareholders equityThe company has negative equity. Total equity: -zł6.8k This is considered a major risk. Being in negative equity means that the company's liabilities exceed its assets, meaning it owes more to creditors than it has in owned assets. While this doesn't mean the company is about to collapse, in the long-term, this is unsustainable. The company may have issues meeting financial obligations, is at risk of becoming insolvent and may have difficulty raising capital, especially more debt, if needed. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-zł329k free cash flow). Negative equity (-zł6.8k). Revenue is less than US$1m (zł250 revenue, or US$60.0). Market cap is less than US$10m (€982.7k market cap, or US$1.06m). Minor Risk Shareholders have been diluted in the past year (3.4% increase in shares outstanding).
공시 • Jun 04Neurone Studio S.A., Annual General Meeting, Jun 30, 2023Neurone Studio S.A., Annual General Meeting, Jun 30, 2023, at 11:00 Central European Standard Time.
공시 • Jan 26+ 2 more updatesNeurone Studio S.A. to Report Q3, 2023 Results on Nov 13, 2023Neurone Studio S.A. announced that they will report Q3, 2023 results on Nov 13, 2023
공시 • Jun 08Neurone Studio S.A., Annual General Meeting, Jun 30, 2022Neurone Studio S.A., Annual General Meeting, Jun 30, 2022, at 13:00 Central European Standard Time.
공시 • Feb 02+ 4 more updatesNeurone Studio S.A. to Report Q3, 2022 Results on Nov 11, 2022Neurone Studio S.A. announced that they will report Q3, 2022 results on Nov 11, 2022
Is New 90 Day High Low • Feb 13New 90-day low: €0.71The company is down 22% from its price of €0.92 on 13 November 2020. The German market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Entertainment industry, which is up 13% over the same period.
공시 • Jan 29+ 3 more updatesNeurone Studio S.A. to Report Fiscal Year 2020 Results on May 27, 2021Neurone Studio S.A. announced that they will report fiscal year 2020 results on May 27, 2021
Is New 90 Day High Low • Oct 26New 90-day low: €0.85The company is down 27% from its price of €1.17 on 28 July 2020. The German market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Entertainment industry, which is up 20% over the same period.
Is New 90 Day High Low • Sep 29New 90-day low: €0.85The company is down 14% from its price of €1.00 on 01 July 2020. The German market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Entertainment industry, which is up 8.0% over the same period.